Announcements

4 December 2025
Cells | Highly Cited Papers Published in 2024 in the “Autophagy” Section


Macro-autophagy, micro-autophagy, and chaperone-mediated autophagy are lysosomal degradative processes that allow cells to eliminate unwanted or dysfunctional protein/protein complexes, superfluous or damaged organelles, and invading pathogens. In most scenarios, autophagy processes specifically target structures that cells do not want. As a result, they are involved in a multitude of physiological functions and pathological situations. Autophagy is currently one of the fastest-growing research areas in life and medical sciences.

The “Autophagy” Section of Cells (ISSN 2073-4409) aims to be an active part of the international autophagy research community and aims to attract manuscripts detailing the latest cutting-edge research on autophagy across kingdoms.

1. “Bitter Taste Receptor T2R14 and Autophagy Flux in Gingival Epithelial Cells”
by Nisha Singh, Ben Ulmer, Manoj Reddy Medapati, Christine Zhang, Robert J. Schroth, Saeid Ghavami and Prashen Chelikani
Cells 2024, 13(6), 531; https://doi.org/10.3390/cells13060531
Available online: https://www.mdpi.com/2073-4409/13/6/531

2. “TRIM44, a Novel Prognostic Marker, Supports the Survival of Proteasome-Resistant Multiple Myeloma Cells”
by Trung Vu, Yuqin Wang, Annaliese Fowler, Anton Simieou and Nami McCarty
Cells 2024, 13(17), 1431; https://doi.org/10.3390/cells13171431
Available online: https://www.mdpi.com/2073-4409/13/17/1431

3. “Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy”
by Madhumita S. Manivannan, Xiaoyan Yang, Nirav Patel, Anthea Peters, James B. Johnston and Spencer B. Gibson
Cells 2024, 13(12), 1041; https://doi.org/10.3390/cells13121041
Available online: https://www.mdpi.com/2073-4409/13/12/1041

4. “An Intrinsic Host Defense against HSV-1 Relies on the Activation of Xenophagy with the Active Clearance of Autophagic Receptors”
by Camila Pino-Belmar, Rayén Aguilar, Guillermo E. Valenzuela-Nieto, Viviana A. Cavieres, Cristóbal Cerda-Troncoso, Valentina C. Navarrete, Paula Salazar, Patricia V. Burgos, Carola Otth and Hianara A. Bustamante
Cells 2024, 13(15), 1256; https://doi.org/10.3390/cells13151256
Available online: https://www.mdpi.com/2073-4409/13/15/1256

5. “Distinct UPR and Autophagic Functions Define Cell-Specific Responses to Proteotoxic Stress in Microglial and Neuronal Cell Lines”
by Helena Domínguez-Martín, Elena Gavilán, Celia Parrado, Miguel A. Burguillos, Paula Daza and Diego Ruano
Cells 2024, 13(24), 2069; https://doi.org/10.3390/cells13242069
Available online: https://www.mdpi.com/2073-4409/13/24/2069

6. “Molecular Mechanism of Autophagosome–Lysosome Fusion in Mammalian Cells”
by Po-Yuan Ke
Cells 2024, 13(6), 500; https://doi.org/10.3390/cells13060500
Available online: https://www.mdpi.com/2073-4409/13/6/500

7. “The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases”
by Mousumi Ghosh and Damien D. Pearse
Cells 2024, 13(22), 1834; https://doi.org/10.3390/cells13221834
Available online: https://www.mdpi.com/2073-4409/13/22/1834

8. “Molecular Mechanisms of Autophagy Decline during Aging”
by Shaun H. Y. Lim, Malene Hansen and Caroline Kumsta
Cells 2024, 13(16), 1364; https://doi.org/10.3390/cells13161364
Available online: https://www.mdpi.com/2073-4409/13/16/1364

20 November 2025
Cells | Highly Cited Papers Published in 2024 in the “Cell Proliferation and Division” Section


All cells are exposed to diverse and partially conflicting exogenous or endogenous signaling events that govern cell proliferation, cell cycle arrest, or cell cycle exit into quiescence, temporal or terminal differentiation, or senescence. These signaling events are connected to the machinery that controls the cell division cycle. Within the Section “Cell Proliferation and Division” of Cells (ISSN: 2073-4409), we encourage the submission of manuscripts (original work or reviews) focusing on all aspects of mitogen, metabolic and antiproliferative signaling, and its connection to cell cycle machinery, as well as mechanistical or structural studies of cell cycle control and cell cycle checkpoints. These can include various model systems studying normal cell proliferation or cancer biology. We also encourage the submission of studies addressing all aspects of cell cycle control.

You have free and unlimited access to the full texts of all of the open access articles published in our journal. We welcome you to read our most highly cited papers published in 2024 below:

1. “Nuclear mTOR Signaling Orchestrates Transcriptional Programs Underlying Cellular Growth and Metabolism”
by Tinghan Zhao, Jialin Fan, Ahmed Abu-Zaid, Stephen K. Burley and X.F. Steven Zheng
Cells 2024, 13(9), 781; https://doi.org/10.3390/cells13090781
Available online: https://www.mdpi.com/2073-4409/13/9/781

2. “Globospiramine from Voacanga globosa Exerts Robust Cytotoxic and Antiproliferative Activities on Cancer Cells by Inducing Caspase-Dependent Apoptosis in A549 Cells and Inhibiting MAPK14 (p38α): In Vitro and Computational Investigations”
by Joe Anthony H. Manzano, Elian Angelo Abellanosa, Jose Paolo Aguilar, Simone Brogi, Chia-Hung Yen, Allan Patrick G. Macabeo and Nicanor Austriaco
Cells 2024, 13(9), 772; https://doi.org/10.3390/cells13090772
Available online: https://www.mdpi.com/2073-4409/13/9/772

3. “Uncovering miRNA–mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of BRCA2MUT Ovarian Cancer PEO1-OR Cells with the ATR/CHK1 Pathway Inhibitors”
by Łukasz Biegała, Damian Kołat, Arkadiusz Gajek, Elżbieta Płuciennik, Agnieszka Marczak, Agnieszka Śliwińska, Michał Mikula and Aneta Rogalska
Cells 2024, 13(10), 867; https://doi.org/10.3390/cells13100867
Available online: https://www.mdpi.com/2073-4409/13/10/867

4. “Expression Profiling Identified TRPM7 and HER2 as Potential Targets for the Combined Treatment of Cancer Cells”
by Miyuki Egawa, Eva Schmücker, Christian Grimm, Thomas Gudermann and Vladimir Chubanov
Cells 2024, 13(21), 1801; https://doi.org/10.3390/cells13211801
Available online: https://www.mdpi.com/2073-4409/13/21/1801

5. “Preserving Genome Integrity: Unveiling the Roles of ESCRT Machinery”
by Mattia La Torre, Romina Burla and Isabella Saggio
Cells 2024, 13(15), 1307; https://doi.org/10.3390/cells13151307
Available online: https://www.mdpi.com/2073-4409/13/15/1307

6. “Cytosolic and Acrosomal pH Regulation in Mammalian Sperm”
by Julio C. Chávez, Gabriela Carrasquel-Martínez, Sandra Hernández-Garduño, Arturo Matamoros Volante, Claudia L. Treviño, Takuya Nishigaki and Alberto Darszon
Cells 2024, 13(10), 865; https://doi.org/10.3390/cells13100865
Available online: https://www.mdpi.com/2073-4409/13/10/865

7. “The Crosstalk of Apoptotic and Non-Apoptotic Signaling in CD95 System”
by Kamil Seyrek, Johannes Espe, Elisabeth Reiss and Inna N. Lavrik
Cells 2024, 13(21), 1814; https://doi.org/10.3390/cells13211814
Available online: https://www.mdpi.com/2073-4409/13/21/1814

8. “Peto’s “Paradox” and Six Degrees of Cancer Prevalence”
by Andras Szasz
Cells 2024, 13(2), 197; https://doi.org/10.3390/cells13020197
Available online: https://www.mdpi.com/2073-4409/13/2/197

11 November 2025
Cells | Highly Cited Papers Published in 2024 in the “Cell and Gene Therapy” Section


Cell gene therapy involves two aspects: cell therapy and gene therapy. Cell therapy is a method that uses the patient’s own cells or donor cells to stimulate an immune response or cell regeneration to kill pathogens and tumor cells. It includes immune cell therapy, stem cell therapy, and somatic cell therapy. Gene therapy is an approach based on treating disease by modifying (through introduction, removal, and change) the patient's genes. In recent decades, research on cell and gene therapy has developed rapidly, and this is now emerging as an alternative therapy for many diseases.

The “Cell and Gene Therapy” Section of Cells (ISSN: 2073-4409) aims to support research that focuses on the research progress of cell gene therapy in tumors, genetic diseases, cardiovascular diseases, autoimmune diseases, and certain rare diseases. We welcome original research articles, review articles, and communications on topics in this field.

You have free and unlimited access to the full texts of all of the open access articles published in our journal. We invite you to read our most highly cited papers published in 2024, which are listed below:

1. “Dual Targeting of Glioblastoma Cells with Bispecific Killer Cell Engagers Directed to EGFR and ErbB2 (HER2) Facilitates Effective Elimination by NKG2D-CAR-Engineered NK Cells”
by Anne Kiefer, Maren Prüfer, Jasmin Röder, Jordi Pfeifer Serrahima, Malena Bodden, Ines Kühnel, Pranav Oberoi and Winfried S. Wels
Cells 2024, 13(3), 246; https://doi.org/10.3390/cells13030246
Available online: https://www.mdpi.com/2073-4409/13/3/246

2. “Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling”
by Wafaa A. Aljagthmi, Manal A. Alasmari, Maha H. Daghestani, Layla A. Al-Kharashi, Falah H. Al-Mohanna and Abdelilah Aboussekhra
Cells 2024, 13(8), 680; https://doi.org/10.3390/cells13080680
Available online: https://www.mdpi.com/2073-4409/13/8/680

3. “Comparison of Minced Cartilage Implantation with Autologous Chondrocyte Transplantation in an In Vitro Inflammation Model”
by Robert Ossendorff, Lisa Grede, Sebastian Scheidt, Andreas C. Strauss, Christof Burger, Dieter C. Wirtz, Gian M. Salzmann and Frank A. Schildberg
Cells 2024, 13(6), 546; https://doi.org/10.3390/cells13060546
Available online: https://www.mdpi.com/2073-4409/13/6/546

4. “Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo”
by Shahab Mamaghani, Rocco Roberto Penna, Julia Frei, Conrad Wyss, Mark Mellett, Thomas Look, Tobias Weiss, Emmanuella Guenova, Thomas M. Kündig, Severin Lauchli et al.
Cells 2024, 13(15), 1242; https://doi.org/10.3390/cells13151242
Available online: https://www.mdpi.com/2073-4409/13/15/1242

5. “Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling—New Cues on CAT-VTE”
by Catarina Freitas-Dias, Filipe Gonçalves, Filipa Martins, Isabel Lemos, Luís G. Gonçalves and Jacinta Serpa
Cells 2024, 13(4), 305; https://doi.org/10.3390/cells13040305
Available online: https://www.mdpi.com/2073-4409/13/4/305

6. “Lung Transplant Immunomodulation with Genetically Engineered Mesenchymal Stromal Cells—Therapeutic Window for Interleukin-10”
by Antti I. Nykänen, Andrea Mariscal, Allen Duong, Aadil Ali, Akihiro Takahagi, Xiaohui Bai, Guan Zehong, Betty Joe, Mamoru Takahashi, Manyin Chen et al.
Cells 2024, 13(10), 859; https://doi.org/10.3390/cells13100859
Available online: https://www.mdpi.com/2073-4409/13/10/859

7. “Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?”
by Caroline Lonez and Eytan Breman
Cells 2024, 13(2), 146; https://doi.org/10.3390/cells13020146
Available online: https://www.mdpi.com/2073-4409/13/2/146

8. “The Role of Stem Cells as Therapeutics for Ischaemic Stroke”
by Jingyuan Ya, Jessica Pellumbaj, Arshad Hashmat and Ulvi Bayraktutan
Cells 2024, 13(2), 112; https://doi.org/10.3390/cells13020112
Available online: https://www.mdpi.com/2073-4409/13/2/112

9. “Variation of Structure and Cellular Functions of Type IA Topoisomerases across the Tree of Life”
by Kemin Tan and Yuk-Ching Tse-Dinh
Cells 2024, 13(6), 553; https://doi.org/10.3390/cells13060553
Available online: https://www.mdpi.com/2073-4409/13/6/553

10. “Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson’s Disease”
by Woong Choi, Seongkwang Cha and Kyoungmi Kim
Cells 2024, 13(14), 1214; https://doi.org/10.3390/cells13141214
Available online: https://www.mdpi.com/2073-4409/13/14/1214

6 November 2025
Meet Us at the Multiomics and Precision Medicine Joint Conference 2025 (MOPM2025), 8–9 November 2025, Taipei, Taiwan


Conference:
Multiomics and Precision Medicine Joint Conference 2025
Date: 8–9 November 2025
Place: Taipei, Taiwan

We are excited to announce that MDPI will be attending the Multiomics and Precision Medicine Joint Conference 2025 (MOPM 2025) as an exhibitor and proud sponsor of the Special Poster Award Sponsorship, which will recognize six recipients of the MDPI Rising Star Poster Awards.

Now in its seventh edition, MOPM serves as Taiwan’s leading academic platform dedicated to integrative multiomics and precision medicine research. Organized jointly by six major scientific societies, the conference promotes interdisciplinary collaboration across life sciences, medicine, and data science.

This year’s theme, “Big Data and AI Revolution for Next-Generation Precision Medicine”, will highlight cutting-edge applications of artificial intelligence and big data in biotechnology and healthcare. The program will feature plenary talks from international experts, poster presentations, industry showcases, and exhibitions of the latest research and technologies — fostering dialogue and collaboration among scholars and professionals across disciplines.

The following MDPI journals will be represented:

If you will be attending this conference, our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.mopmtaiwan.com.

4 November 2025
MDPI INSIGHTS: The CEO's Letter #28 - WSF11, Nobel Laureates, Proofig AI, Romania Summit, STM and FBF

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Highlights from the 11th World Sustainability Forum in Barcelona

I’m pleased to share some highlights from the 11th World Sustainability Forum (WSF 11), held in Barcelona on 2–3 October 2025 under the theme Sustainable and Resilient Cities.

Why WSF matters

The WSF series is a flagship initiative for MDPI and is supported by the MDPI Sustainability Foundation. It serves as a transdisciplinary platform for researchers, policymakers, and stakeholders to engage on sustainability challenges. WSF is now held annually as part of our commitment to maintain momentum in the sustainability discourse.

This year’s Barcelona edition focused on urban resilience, landscape design, and social community impact in the sustainability space. Over 48 hours of sessions, we brought together leading minds across disciplines to translate vision into practice. With participants from 53 countries across all continents, WSF 11 was truly global in scope.

“WSF is now held annually as part of our commitment to maintain momentum in the sustainability discourse”

What made WSF 11 especially successful (from my vantage point) was the level of positive engagement with our participants. Chief editors, researchers, and attendees repeatedly told me how professionally executed the event was, highlighting the high energy, logistical smoothness and quality of MDPI’s event management. That kind of recognition from peers really builds our reputation as more than just a publisher, but as a convener of meaningful scientific dialogue.

Our conferences are a form of experiential marketing as they create memorable and immersive connections between a brand and attendees. These positive associations build promotion and brand loyalty, ultimately impacting the MDPI’s trust and reputation for the better.

WSF 11: By the numbers

Here’s a quick snapshot of WSF 11’s scale and reach:

  • 181 registrations across global participants.
  • 8 keynote speakers and 5 invited speakers.
  • 144 abstracts accepted (over 355 submitted), resulting in 75 short talks and 69 posters.
  • 53 countries were represented across all continents, making it a truly international event.
  • First time that we ran parallel sessions for WSF (an ambitious program).
  • A dedicated awards ceremony to honour outstanding sustainability research: World Sustainability Award (WSA) x 2 winners, and Emerging Sustainability Leader Award (ESLA) x 3 winners.

Interviews with our World Sustainability Award Winners

One of the most rewarding parts of WSF is recognizing researchers whose work advances sustainability in powerful ways. In our Blog series, Daniella Maritan-Thomson (Content Specialist, MDPI) interviewed the two winners of the World Sustainability Award, Professor Dr. Stuart Pimm and Dr. Abdelbagi M. Ismail, who offered insights to the human side of sustainability research, the people behind the data, and the stories behind the science.

Prof. Stuart Pimm, whose decades of conservation work make him a leader in biodiversity preservation, reflected on his WSF Award experience and research in this interview: [Interview: Prof Stuart Pimm]

Dr. Abdelbagi M. Ismail, an expert in crop improvement and winner of the WSF Award, shares his journey and perspectives here: [Interview: Dr Abdelbagi M. Ismail]

“Our conferences create memorable and immersive connections”

Emerging Sustainability Leader Award winners


Stefan Tochev (CEO, MDPI), Prof. Dr. Vhahangwele Masindi, Dr. Katya Rhodes, and Prof. Dr. Myriam Ertz (left to right).

We also recognized three recipients of the Emerging Sustainability Leader Award: Prof. Dr. Vhahangwele Masindi, Dr. Katya Rhodes, and Prof. Dr. Myriam Ertz, for their contributions as early-career researchers advancing sustainability through innovation, impact, and academic excellence across the field.

What this means for MDPI

  1. Building our global identity in events
    WSF is a marquee MDPI event, not just a gathering, but a statement of how we wish to position ourselves in the global sustainability ecosystem. The positive feedback helps us build on our approach for future editions, so that we remain a reference point for quality, relevance, and engagement.
  2. Expanding capacity across offices
    The success of WSF 11 in Barcelona’s would not have happened without great teamwork from Basel, Barcelona, Romania, the UK, and the APAC Conference team. Thanks to everyone for their work to bring this ambitious event to life.
  3. Supporting MDPI’s mission
    At this event, I had the opportunity to present on MDPI's role in Open Access, sustainability publishing, and the intersection of science and policy. WSF is not only about the science; it’s also a platform for us to position MDPI as a thought leader and a collaborator in shaping the future of sustainable research.

I look forward to the WSF momentum as we work towards WSF 12 in Hong Kong, which is scheduled for August 2026.


MDPI Colleagues at the 11th World Sustainability Forum in Barcelona, Spain, 2–3 October 2025.

Impactful Research

Celebrating 2025 Nobel Laureates who have published with MDPI

October is always an inspiring month in science. It’s when the world turns its attention to the Nobel Prize announcements, recognizing discoveries that have changed how we understand the world.

Over the years, many distinguished researchers who have received the Nobel Prize have chosen to publish their work with MDPI. These are scientists whose breakthroughs have shaped entire fields of research, and who have entrusted our Open Access journals to share their findings with the world.

“The work we support can be world-class and world-changing”

Congratulations to the 2025 Laureates

Dozens of Nobel Laureates have published in our journals: as at 2024, more than 40 laureates had contributed over 115 articles across more than 35 MDPI journals. Congratulations to the three 2025 Nobel prize-winners who have published with MDPI during their careers. Below are links to their MDPI publications and announcements for further reading:

These connections strengthen our mission to make research freely available and ensure that transformative ideas reach the widest possible audience.

Publishing at the leading edge of knowledge

The privilege of hosting such contributors resonates deeply with our editorial teams. It shows that top-tier scientific work has a home at MDPI, which builds our visibility in the research community. It signals that our publishing model, our editorial workflows, and our commitment to Open Access are respected at the very highest levels of science. It also gives our authors, reviewers, editors and staff the message that the work we support can be world-class and world-changing.

Publishing at the leading edge of knowledge isn’t just about individual papers – it’s about the ecosystem of support, transparency, and accessibility that makes discovery possible. Let’s continue to build a publishing platform and provide a service that attracts and enables both everyday research and the breakthroughs of tomorrow.

Inside MDPI

Strengthening Research Integrity: MDPI partners with Proofig AI

I’m pleased to share that MDPI has entered a multi-year partnership with Proofig AI, a leader in AI-driven proofing and integrity software for scientific publishing. This follows the success of our pilot program, in which Proofig AI proved highly effective in detecting duplicated, altered, and manipulated images across biomedical submissions.

Safeguarding the credibility of the research we publish

Research integrity is at the core of MDPI’s mission. The life sciences, in particular, face increasing risks of image-related issues due to advanced editing tools and generative AI. By integrating Proofig AI into our workflows, we improve our ability to detect issues early, reduce post-publication corrections, and safeguard the credibility of the research we publish.

Pilot outcomes

  • Successful detection of duplicated confocal and histology images, even when altered to disguise similarities.
  • Early results showed a significant drop in post-publication image manipulation flags year-on-year.
  • Positive feedback from editors and staff highlighted the tool’s ease of use and reliability.

Dr. Dror Kolodkin-Gal (co-founder and CEO of Proofig AI) said: 

“The MDPI team conducted a highly professional and carefully monitored pilot, achieving excellent results in detecting problematic images.

Their fast and effective integration process was impressive, and we are excited to contribute to this important collaboration.”

Sanita Meijere (IT Product and Project Manager, MDPI), shared:

“For more than a year, we’ve tested all the available image manipulation detection tools. Proofig AI’s quality and ease of use, alongside positive feedback from our internal users, made their software a clear stand-out.

We’re thrilled to be moving forward with this partnership, ensuring we do our utmost to protect MDPI’s biomedical journals. Using this advanced image proofing software reaffirms MDPI’s commitment to maintaining the highest standards in research integrity.”

Raising the bar for integrity

This partnership sets a new benchmark for quality control in biomedical publishing.

As Tim Tait-Jamieson (Head of Publication Ethics, MDPI), explains:

“The life sciences are disproportionately affected by research integrity issues, making vigilance in this field especially critical. This is driven, in part, by the increasing sophistication of image editing software and generative AI.

Whether accidental or deliberate, image manipulation can have a lasting impact on credibility. By integrating Proofig AI into our editorial workflows, we strengthen our ability to detect scientific misconduct early and reduce post-publication amendments.”

Faster and more accurate quality control

Proofig will automatically flag potentially problematic images during submission checks, giving our editors more confidence in the integrity of manuscripts and freeing up time to focus on editorial decisions. The tool will also reduce the burden of manual checks, while supporting faster and more accurate quality control. This partnership reinforces MDPI's reputation as a publisher that takes integrity seriously and continues to invest in tools to support authors, editors, and reviewers alike.

A big thank-you to all colleagues who supported the pilot and rollout. You can read more in our MDPI Blog post.

Coming Together for Science

The MDPI Romania Summit 2025

On 21–22 October, I had the pleasure of joining our colleagues in Bucharest for the MDPI Romania Summit 2025. The event was organized by our Romania Marketing team, with support from colleagues across our Romanian offices. It brought together academics, policymakers, and collaborators to discuss the country’s evolving research landscape.

Over two days, we welcomed more than 30 participants, including Editorial Board Members, Guest Editors, and policy-makers from the Romanian research and education sectors, including representatives from the Romanian Academy and the National Commission for the Accreditation of Academic Titles (CNATDCU).

The discussions and presentations reflected the strength and growth of Romania’s research community and its active engagement in Open Access publishing.

“The discussions and presentations reflected the strength and growth of Romania’s research community”

Romania’s role in Open Access

Romania loves Open Access and has emerged as one of MDPI’s most engaged national research communities. The numbers speak for themselves:

  • 67% of all publications in Romania were Open Access in 2024.
  • MDPI accounts for 39% of the country’s total OA publications (14,779 in 2024).
  • Over the last five years (2020–2024), Romanian institutions published over 33,000 papers with MDPI.
  • There are 460 active Editorial Board Members from Romania, including 8 Chief Editors.
  • 29 institutions are part of our Institutional Open Access Program (IOAP), with 8 new members joining in 2025.

These numbers reflect the trust and reliable partnership we have built with the Romanian academic community.

Highlights from the Summit

The program covered a wide range of topics from MDPI’s achievements and updates to our editorial processes, peer-review quality, AI in publishing, IOAP and Open Access funding models, and publication ethics.

Agenda Highlights:

  • MDPI Introduction, Performance & Achievements, and Collaboration with Romania – Stefan Tochev (CEO, MDPI).
  • Trust the Process: Editorial Workflow and Quality in Publishing – Dr. Liliane Auwerter (Scientific Review Group).
  • Publication Ethics at MDPI: Safeguarding the Integrity of the Published Scholarly Record – Diana Cristina Apodaritei (Research Integrity Specialist).
  • Institutional Partnerships – Becky Castellon (Institutional Partnerships Manager, MDPI).
  • AI in Publishing and MDPI's Actions – Sanita Meijere (AI Product Manager).
  • Closing Remarks – Stefan Tochev (CEO, MDPI).

Participants shared feedback and ideas for future collaborations, including organizing author workshops, possible conference collaborations, and strengthening our engagement with national institutions such as the Ministry of Education and Research and the National Council of Romanian Rectors.

As Acad. Dr. Nicolae-Victor Zamfir, Vice President of the Romanian Academy, noted during the discussions:

“The organization of the event is very timely, because MDPI is a publishing house in full development and expansion. The opinion of researchers is important for increasing the quality of published works.”

A collaborative future

Events like this remind us how essential it is to engage locally and listen directly to the voices of our editors, authors, and institutional partners. They help us build relationships, improve our understanding of the local market, and align our shared goals in advancing Open Access and research quality.

Thank you to everyone involved, especially our Romania Marketing team, who organized the event, and to all colleagues who continue to build relationships with our academic communities around the world.

Thank you!

A special thank-you to the Romanian Marketing team and all colleagues behind the scenes who made this Summit such a success. Your efforts are greatly appreciated. We look forward to building on this momentum with future Summits in Europe and beyond.

Closing Thoughts

STM and FBF 2025: Connecting Through Science and Publishing


Stefan Tochev (CEO, MDPI), Constanze Schelhorn (Head of Indexing, MDPI) at STM Conference, Frankfurt, 14 October 2025.

On 13–14 October, I attended the STM Frankfurt Conference 2025, my fourth visit to the Frankfurt event, and it continues to be one of the most valuable gatherings in our industry.

The STM meeting brings together the publishing community and key opinion leaders to speak on current trends and challenges shaping our industry.

This year’s theme – “Science Diplomacy: What is it and How Does it Work?” – unpacked the growing intersection of science, policy, and publishing.

Discussion topics ranged from what is science diplomacy and how publishers can contribute to global collaboration to how science communication can help maintain trust during an era of disruption.

I was joined by Dr. Constanze Schelhorn, our Head of Indexing, who met with representatives from Scopus, Web of Science, Digital Science, ProQuest, and other partners. These meetings give us a chance to share feedback on our collaborations, learn about new updates being developed, and build our relationships with indexing bodies.

“The STM meeting brings together the publishing community and key opinion leaders”

STM also provides a space to connect with industry peers, as I did with colleagues from Elsevier, Frontiers, Clarivate, Sage, and STM itself, reinforcing MDPI’s engagement within the broader publishing community. It was also nice to bump into some former colleagues and see them continuing to grow in their publishing careers.

At the Frankfurt Book Fair


The MDPI booth at the 2025 Frankfurt Book Fair.

Following STM, I spent the next day at the Frankfurt Book Fair (15–19 October) – one of the largest and most influential events in the publishing world.

It’s always inspiring to see the scale and energy of this global gathering, which spans everything from books and education to digital innovation and academic publishing.

We set up an MDPI booth to host discussions with partners, vendors, and researchers.

The Fair ran into the weekend, with colleagues from several MDPI departments attending to represent the company and connect with the scholarly community.


Events like STM and FBF are a nice reminder of how dynamic and interconnected our industry is, and how important it is for MDPI to continue taking part in global conversations about science, communication, and the future of publishing.

Stefan Tochev
Chief Executive Officer
MDPI AG

28 October 2025
Cells | Highly Cited Papers Published in 2024 in the “Cell Nuclei: Function, Transport and Receptors” Section


The main function of the nucleus is to control cell growth and reproduction via regulating gene expression, DNA replication, and protein production. The “Cell Nuclei: Function, Transport and Receptors” Section of Cells (ISSN: 2073-4409) aims to publish findings that provide novel phenomena and/or conceptual advances to the field.

You have free and unlimited access to the full texts of all of the open access articles published in our journal. We welcome you to read our most highly cited papers published in 2024 below:

1. “NF-κB as an Inducible Regulator of Inflammation in the Central Nervous System”
by Sudha Anilkumar and Elizabeth Wright-Jin
Cells 2024, 13(6), 485; https://doi.org/10.3390/cells13060485
Available online: https://www.mdpi.com/2073-4409/13/6/485

2. “De Novo Cancer Mutations Frequently Associate with Recurrent Chromosomal Abnormalities during Long-Term Human Pluripotent Stem Cell Culture”
by Diana Al Delbany, Manjusha S. Ghosh, Nuša Krivec, Anfien Huyghebaert, Marius Regin, Mai Chi Duong, Yingnan Lei, Karen Sermon, Catharina Olsen and Claudia Spits
Cells 2024, 13(16), 1395; https://doi.org/10.3390/cells13161395
Available online: https://www.mdpi.com/2073-4409/13/16/1395

3. “Desmin and Plectin Recruitment to the Nucleus and Nuclei Orientation Are Lost in Emery-Dreifuss Muscular Dystrophy Myoblasts Subjected to Mechanical Stimulation”
by Vittoria Cenni, Camilla Evangelisti, Spartaco Santi, Patrizia Sabatelli, Simona Neri, Marco Cavallo, Giovanna Lattanzi and Elisabetta Mattioli
Cells 2024, 13(2), 162; https://doi.org/10.3390/cells13020162
Available online: https://www.mdpi.com/2073-4409/13/2/162

4. “Synergistic Roles of Non-Homologous End Joining and Homologous Recombination in Repair of Ionizing Radiation-Induced DNA Double Strand Breaks in Mouse Embryonic Stem Cells”
by Gerarda van de Kamp, Tim Heemskerk, Roland Kanaar and Jeroen Essers
Cells 2024, 13(17), 1462; https://doi.org/10.3390/cells13171462
Available online: https://www.mdpi.com/2073-4409/13/17/1462

5. “Deletion of the Murine Ortholog of the Human 9p21.3 Locus Leads to Insulin Resistance and Obesity in Hypercholesterolemic Mice”
by Sanna Kettunen, Tuisku Suoranta, Sadegh Beikverdi, Minja Heikkilä, Anna Slita, Iida Räty, Elias Ylä-Herttuala, Katariina Öörni, Anna-Kaisa Ruotsalainen and Seppo Ylä-Herttuala
Cells 2024, 13(11), 983; https://doi.org/10.3390/cells13110983
Available online: https://www.mdpi.com/2073-4409/13/11/983

6. “Lamin A/C and PI(4,5)P2—A Novel Complex in the Cell Nucleus”
by Sara Escudeiro-Lopes, Vlada V. Filimonenko, Lenka Jarolimová and Pavel Hozák
Cells 2024, 13(5), 399; https://doi.org/10.3390/cells13050399
Available online: https://www.mdpi.com/2073-4409/13/5/399

7. “Contribution of AurkA/TPX2 Overexpression to Chromosomal Imbalances and Cancer”
by Federica Polverino, Anna Mastrangelo and Giulia Guarguaglini
Cells 2024, 13(16), 1397; https://doi.org/10.3390/cells13161397
Available online: https://www.mdpi.com/2073-4409/13/16/1397

8. “Nuclear Phospholipids and Signaling: An Update of the Story”
by Irene Casalin, Eleonora Ceneri, Stefano Ratti, Lucia Manzoli, Lucio Cocco and Matilde Y. Follo
Cells 2024, 13(8), 713; https://doi.org/10.3390/cells13080713
Available online: https://www.mdpi.com/2073-4409/13/8/713

9. “Therapeutic Approaches to Targeting Androgen Receptor Splice Variants”
by Violet A. Daniels, Jun Luo, Channing J. Paller and Mayuko Kanayama
Cells 2024, 13(1), 104; https://doi.org/10.3390/cells13010104
Available online: https://www.mdpi.com/2073-4409/13/1/104

10. “Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma”
by Ami Kobayashi, Yosuke Kitagawa, Ali Nasser, Hiroaki Wakimoto, Keisuke Yamada and Shota Tanaka
Cells 2024, 13(5), 457; https://doi.org/10.3390/cells13050457
Available online: https://www.mdpi.com/2073-4409/13/5/457

21 October 2025
Meet Us at the 17th Stem Cell Society Singapore Symposium, 11–14 November 2025, Singapore


MDPI will be exhibiting at the 17th Stem Cell Society Singapore Symposium 2025.

The 17th Stem Cell Society Singapore Symposium 2025 (SCSS 2025) will be held from 11 to 14 November 2025 at Matrix Building, Biopolis, Singapore. The conference is organized by the Stem Cell Society Singapore (SCSS).

This exciting event will bring together leading experts, researchers, and professionals in the biological science field to share their knowledge, present their latest discoveries, and provide valuable networking opportunities.

The following MDPI journals will be represented:

If you are planning to attend the conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.stemcell.org.sg/symposium2025.html.

15 October 2025
MDPI’s Newly Launched Journals in September 2025


Nine new journals covering a range of subjects launched their inaugural issues in September 2025. We are excited to be able to share with you the newest research rooted in the value of open access.

We extend our sincere thanks to all Editorial Board Members for their commitment and expertise. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Joseph G. Grzywacz,

San José State University, USA

Editorial | view inaugural issue

family formation and dynamics; family relationships; family diversity and structure; family processes; family challenges; global perspectives of family |

view journal scope | submit an article

Prof. Dr. Chengkuo Lee,

National University of Singapore, Singapore

Editorial | view inaugural issue

AIoT sensing technologies; distributed AI and federated learning; AI-enhanced edge analytics; sensor fusion in edge computing; low-power AI sensing; security and privacy in edge-AI systems; AI-driven optimization of IoT networks |

view journal scope | submit an article

Prof. Dr. Steven Paul Nistico,

Sapienza University of Rome, Italy

Editorial | view inaugural issue

aesthetics; reconstructive surgery and plastic surgery; dermatology; oral and maxillofacial surgery; surgical procedures; non-surgical procedures |

view journal scope | submit an article

Prof. Dr. Mauro Tonelli,

University of Pisa, Italy

Editorial | view inaugural issue

plasma physics and technology; atomic and molecular physics; nuclear physics; quantum physics and technology; dielectrics, ferroelectrics, and multiferroics; semiconductor physics and devices; engineering physics; material physics; biophysics|

view journal scope | submit an article

Prof. Dr. Sergej M. Ostojic,

University of Agder, Norway;
University of Pécs, Hungary

Editorial | view inaugural issue

biochemical research methods; biochemistry and molecular biology; cell biology; clinical and medicinal chemistry; clinical neurology; endocrinology and metabolism; medicine, general and internal; nutrition and dietetics; toxicology |

view journal scope | submit an article

Prof. Dr. Michele Nappi,

University of Salerno, Italy

Editorial | view inaugural issue

foundations and advancements in multimedia technologies; computational social media analytics; human–AI interaction in social contexts; multimedia understanding and generation for social insight; ethics, fairness, and privacy in multimedia systems |

view journal scope | submit an article

Prof. Dr. Philippe Gorce,

Toulon University, France

Editorial | view inaugural issue

ergonomic design and evaluation of workspaces, tools, and equipment; biomechanical analysis and ergonomic interventions for musculoskeletal health; cognitive workload assessment and management; human-computer interaction (HCI) and user experience (UX) research; ergonomic wearables; AI-driven ergonomic assessment tools; neuroergonomics |

view journal scope | submit an article

Prof. Dr. Ronald Charles Sims,

Utah State University, USA

Editorial | view inaugural issue

bioresources; bioproducts; bioenergy and biofuels; environmental protection; public health protection; biological waste treatment; biomass transformation; circular bioeconomy; bio-based materials and chemicals; bioresidues |

view journal scope | submit an article

Prof. Dr. M. Jamal Deen,

McMaster University, Canada

Editorial | view inaugural issue

device design and engineering; circuit design and system integration; applications and emerging technologies; materials and fabrication innovations; testing, reliability, and standards |

view journal scope | submit an article

We would like to thank everyone who has supported the development of open access publishing. If you would like to create more new journals, you are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com).

13 October 2025
Meet Us at Neuroscience 2025, 15–19 November 2025, San Diego, USA


Conference:
Neuroscience 2025
Date: 15–19 November 2025
Location: San Diego Convention Center, San Diego, USA

Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attendees can present research, network with scientists, attend sessions and events, and browse the exhibit hall. Join the nearly half a million neuroscientists from around the world who have propelled their careers by presenting an abstract at the SfN annual meeting—the premier global neuroscience event.

The following MDPI journals will be presented:

  • Brain Sciences;
  • Cells;
  • Neurology International;
  • Anatomia;
  • Biomedicines;
  • Intell.;
  • Neuroglia;
  • NeuroSci;
  • Psychiatry International;
  • Sclerosis;
  • Biomolecules;
  • Diseases;
  • IJMS;
  • Pathophysiology;
  • Emergency Care and Medicine

Our delegates look forward to meeting you in person at booth No. 3429 at the conference, as well as to answering any questions you may have. For more information regarding the conference, please visit the following link: https://www.sfn.org/meetings/neuroscience-2025.

2 October 2025
MDPI INSIGHTS: The CEO's Letter #27 - OASPA 2025, COUNTER 5.1, UK Summit in London, MDPI at the Italian Senate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI at OASPA 2025: Embracing the Complexity of Open Access

From 22 to 24 September, I joined the OASPA 2025 Annual Conference in Leuven, Belgium, where the theme, “Embracing the Complexity – How do we get to 100% Open Access?” tackled the hard questions about the future of scholarly communication.

With MDPI a longstanding member of the Open Access Scholarly Publishing Association (OASPA) and Platinum sponsor of the conference, I was invited to present and participate in important discussions on how we can continue to move the needle in Open Access (OA) publishing.

From 50% to 100% Open Access

Last year’s OASPA conference celebrated a major milestone – reaching 50% of global research outputs published as OA. But, as noted during the conference, this was the “easy” part. The challenge ahead is much tougher: how do we take OA from 50% to 100%? For many academics and institutions, OA is still relatively new, and thus it is essential for us to continue educating people as to what OA is, how it works, and why it matters.


Stefan Tochev (CEO, MDPI) presenting at OASPA’s 2025 Annual Conference in Leuven, Belgium.

MDPI’s perspective

At MDPI, we are fully committed to this. As a 100% OA publisher, our growth is inseparable from the success of OA itself. In many ways, MDPI is a byproduct of the global adoption of OA, and we play an important role in helping to advance it further.

I had the opportunity to share MDPI’s perspective in the panel discussion entitled: "Hello from the other side: views from fully Open Access journals using APCs," alongside industry colleagues from PLOS, eLife, AOSIS, and Frontiers.

Instead of giving a standard presentation, I highlighted aspects of MDPI that the audience might not be aware of. I also presented on the opportunities and challenges facing publishers that are already fully OA, the importance of diverse models in achieving 100% OA, and why OA is the baseline while Open Science is the future.

 Recognizing Gold OA

As part of the panel, I had undertaken to make some bold and provocative statements. I therefore emphasized a point that is sometimes overlooked: we didn’t reach 50% OA without Gold OA – it accounts for more than half of all OA publications today. And we certainly won’t reach 100% OA without it.

“By educating the community and working together, we can continue to take Open Science to the next level”


“When people speak about Gold OA and MDPI, they should ‘put some respek on our name.”

MDPI is a leader in Gold OA and has been a driver of this progress at scale.

While Gold OA and MDPI are sometimes slighted, both deserve recognition for their contributions to advancing Open Science globally.

I closed my presentation with a reminder that the good we do is sometimes overlooked, and that when people speak about Gold OA and MDPI, they should "put some respek on our name."

I’m pleased to have seen attendees sharing positive experiences with MDPI, reminding us that we bring real value to the OA movement and deserve a stronger reputation. We also engaged in constructive conversations about various topics, including cost transparency.

A few themes that I took away from the conference:

  • Quality and integrity matter as much as access. OA publishers must not lose sight of research integrity, inclusivity, and sustainability while pursuing 100% OA.
  • Global collaboration is essential. Policies, funding models, and infrastructure differ around the world, and we will need cross-border collaboration to make OA a truly global reality.
  • Open Science is the bigger story. OA is just the first step – the future lies in open data, open peer review, research reproducibility, etc.

“MDPI’s scale allows us to better support authors, reinvest in communities, and push Open Science forward”

How we communicate MDPI’s role

For us at MDPI, this is also a reminder of how we communicate externally. When we tell our story, we shouldn’t forget to start with the bigger picture – Open Science and Open Access. Then we connect it to MDPI, our journals, services, and initiatives, exemplifying the fact that we are part of a mission larger than ourselves.


MDPI colleagues Clàudia Aunós (Society Partnerships), Marta Colomer (External Affairs), Stefan Tochev (CEO), and Nikola Paunovic (Scilit), at OASPA’s 2025 Annual Conference in Leuven, Belgium.

The journey to 100% OA will not be simple. But by educating the community and working together, we can continue to take Open Science to the next level.

Impactful Research

MDPI becomes COUNTER 5.1 compliant across 480+ Journals

I’m pleased to share that MDPI has officially become COUNTER 5.1 compliant and has joined the COUNTER Registry.

For those who might not be familiar with it, COUNTER provides international standards for tracking and reporting how research is being used. By becoming COUNTER 5.1 compliant, MDPI can now deliver credible, comparable, and transparent usage reports across our entire journal portfolio.

“MDPI is showing that they want to be measured against the same yardstick as other publishers”

Why is this important?

Because usage statistics aren’t just numbers: they’re powerful tools that help our authors, institutions, and consortia understand the real impact of their research. With COUNTER compliant reports, our institutional partners can now make more informed decisions about publishing agreements, funding allocations, and the long-term value of Open Access.

In practical terms, MDPI will now provide Platform, Title, and Item Reports, with standardized usage views available at the institute and consortium level. These reports cover usage from January 2024 onwards and will be updated monthly. Institutions will be able to access them via SuSy, or automatically through the COUNTER API.

I’d like to highlight and thank Becky Castellon, our Institutional Partnerships Manager, who has played a key role in driving this project forward. Becky captured it perfectly when she said: "Through these usage reports, our global research community can access trustworthy data about how their work is being used and accessed

This information is often vital for reviewing publishing partnership agreements and for making informed decisions about future funding allocations."

We also received encouraging feedback from Tasha Mellins-Cohen, Executive Director at COUNTER Metrics:

"We’re delighted to see born-OA publishers engaging with COUNTER. Our normalised usage metrics are relied on as the basis for credible return-on-investment calculations by libraries worldwide. By adopting the COUNTER standard, MDPI is showing that they want to be measured against the same yardstick as other publishers."

For MDPI, this milestone is another step in our commitment to transparency, trust, and impact. By adopting COUNTER’s standards, we’re not just aligning with best practice; we’re ensuring that Open Access publishing is measured on the same terms as traditional publishing, proving its value in concrete and globally recognized ways.

This is an important milestone for MDPI, but more importantly for the researchers, librarians, and institutions we serve. Transparency builds trust, and COUNTER compliance helps us show the global reach and influence of Open Access publishing in the clearest way possible.


Inside Research


Lin Li (Publisher, MDPI), Stefan Tochev (CEO, MDPI, Prof. Chengkuo Lee (Editor-in-Chief, AI Sensors), and Constanze Schelhorn (Head of Indexing) at restaurant in Basel, Switzerland.

Welcoming Prof. Lee (EiC of AI Sensors) to Basel

On 11 September, we welcomed Prof. Dr. Chengkuo Lee, Editor-in-Chief of our new journal AI Sensors, to our Basel office. Prof. Lee is a high profiled researcher (h-index 104, 37,000+ citations), a longtime collaborator with MDPI (25 published articles), and has already chaired several AI Sensors (AIS)-related conferences with us, including the recent event in Kuala Lumpur, where AI Sensors held its first editorial board meeting.


Stefan Tochev (CEO, MDPI) showing Special Issue reprint books as part of a tour of MDPI’s Basel office.

Every journal has a story

During his visit, we exchanged ideas on how to build the journal’s identity and impact. A key takeaway that I shared was that every journal has a story: its vision, its purpose, and the community it brings together.

That story is what connects with readers and authors, beyond metrics alone.

I encouraged everyone working on journals to reflect: What is the story of your journal? And how can you bring that story to the forefront in how you communicate about it?

How MDPI supports new journals


Constanze Schelhorn (Head of Indexing, MDPI) presenting on the MDPI indexing process at the company’s headquarters in Basel.

We also shared with Prof. Lee how MDPI supports journals through our Institutional Open Access Program, indexing expertise, and the work of our Journal Relationship Specialists.

Launching a new journal is ambitious, but with our strong track record (93% Scopus and 87% Web of Science acceptance rates in 2024), Prof. Lee felt confident that AI Sensors will find its place in the scholarly landscape.

Having spent some hours together, it’s clear that Prof. Lee is not only an Editor-in-Chief but also an ambassador for MDPI. His leadership and collaboration reflect the mission MDPI by which MDPI lives: accelerating Open Access and advancing Open Science.

Special thanks to Constanze Schelhorn (Head of Indexing), Ting Leng (JRS, Managing Editor, AI Sensors), Lin Li (Publisher, AI Sensors), Aimar Xiong (Publisher), and Christian Eberhard (Office Administrator, Basel), for organizing and hosting the meeting.

Coming Together for Science

Highlights from the MDPI UK Summit in London

I was pleased to be back in the UK in September, supporting our Manchester team in hosting their first MDPI Summit in London. This day-and-a-half private event brought together 25 Chief Editors and Associate Editors to exchange knowledge, learn about latest developments at MDPI, and engage in discussions on advancing Open Science. The program included MDPI and guest presentations, and Q&A sessions.

Why these summits matter

Our Summits provide a platform to:

  • Share updates on the latest developments at MDPI, our editorial processes, research integrity practices, and indexing.
  • Highlight collaborations with institutions and societies in the region.
  • Offer external perspectives from guest speakers.
  • Create space for Chief Editors to share their insights, ask questions, network, and help shape MDPI’s path forward.

These gatherings are more than updates: they improve our relationships with Chief Editors, who serve not only as leaders of their journals but also as ambassadors for MDPI within the research community. We often hear that this type of event is unique, something many other publishers do not provide. It shows that we care and are willing to go the extra mile to recognize and engage our key collaborators.

MDPI and the UK: Key facts

  • With over 80,000 publications, the UK is MDPI’s eighth-largest contributor.
  • MDPI is the fourth-largest publisher in the UK, accounting for 11% of the country’s 89,526 Open Access publications in 2024.
  • We collaborate with more than 4,000 active UK Editorial Board Members, 48% of whom have an H-index above 26. This includes 49 Editors-in-Chief and 74 Section Editors-in-Chief.
  • MDPI maintains over 1,000 IOAP agreements worldwide, with 63 from the UK.

“We are willing to go the extra mile to recognize and engage our key collaborators”

Agenda highlights:

  • MDPI Overview, Open Access, and UK Collaboration – Stefan Tochev (CEO, MDPI)
  • MDPI Editorial Process – Dr. Michael O’Sullivan (Scientific Quality Advisor Lead, MDPI)
  • Research Integrity and Publication Ethics – Daisy Fenton (Research Integrity Specialist, MDPI)
  • Institutional Partnerships – Becky Castellon (Institutional Partnerships Manager, MDPI)
  • Promoting and Developing Your Journal – Prof. Fabio Tosti (Editor-in-Chief of NDT)
  • Indexing to Impact – Dr. Michael O’Sullivan (Scientific Quality Advisor Lead, MDPI)
  • Engaging our Academic Community – Jaime Anderson Anderson (UK Operations Manager, MDPI)
  • Closing Remarks – Stefan Tochev (CEO, MDPI)


MDPI colleagues Stefan Tochev (CEO), Jaime Anderson Anderson (UK Operations Manager), Dr. Michael O’Sullivan (Scientific Quality Advisor Lead), Becky Castellon (Institutional Partnerships Manager), Daisy Fenton (Research Integrity Specialist) at the MDPI UK 2025 Summit in London.

Thank you!

A special thank-you to the Manchester team and all colleagues behind the scenes who made this Summit a success. Your efforts are greatly appreciated. We look forward to building on this momentum with future Summits in Europe and beyond.


Closing Thoughts


Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI) and Stefan Tochev (CEO, MDPI) participating in a press conference at the Italiane Senate in Rome to promote the 2nd International Conference on Environmental Medicine (ICEM)

MDPI at the Italian Senate: Promoting Environmental Medicine and Open Science

On 16 September, Dr. Giulia Stefenelli (Scientific Communications Lead) and I had the honour of participating in a press conference at the Italian Senate in Rome, organized by the Italian Society of Environmental Medicine (SIMA) to promote the upcoming 2nd International Conference on Environmental Medicine (ICEM) (20–21 November 2025).

This is an important event for MDPI, as we are the exclusive publishing partner for ICEM and have recently launched a new journal with SIMA, further building our presence both in Italy and within this important field of research.

Why this matters

  • The promotion of ICEM has received extensive national media coverage (more than 15 mentions in major Italian outlets; see links below).
  • The press conference brought together leading policymakers, academics, and Nobel Laureates to emphasize the impact of environmental exposures and epigenetics on human health.
  • We were introduced to government ministries, university rectors, and influential stakeholders, which helps us bolster MDPI’s visibility and reputation in Italy.

Highlights

Nobel Laureate Sir Richard Roberts joined the discussion, underlining the importance of environmental medicine in shaping future health outcomes. Nobel Laureate Prof. Dr. Tong Zhu (Peking University) will also speak at the November conference.

Institutional representatives included the Italian Minister of the Environment and Energy Security, the Italian Undersecretary for Health, and senior officials from the World Health Organization.

In my closing remarks, I highlighted that:

“Over the past five years, about 65% of research published in Italy has been Open Access, compared to an average of 55% worldwide.”

Italian research ranked seventh among the top 20 countries in average citations during this period, reflecting its strong international influence. Not only is Italy producing a high volume of research; it is also producing research of outstanding quality.

MDPI’s role

This event was not only about promoting ICEM but also about showcasing MDPI’s commitment to Open Access and our ability to connect scientific publishing with leading academic, medical, and policy institutions.

As Giulia Stefenelli noted:

“This event was highly relevant for MDPI, as it not only showcased our strong commitment to OA but also emphasized our role in advancing important fields such as Environmental Medicine.”

Learn more

This moment at the Italian Senate shows how MDPI can connect publishing with science, policy, and society to help advance both Open Science and environmental health research on a global stage.

In Rome with Sir Richard Roberts (photo left) and Prof. Giuseppe Novelli (EiC of MDPI journal COVID).

Stefan Tochev
Chief Executive Officer
MDPI AG

Back to TopTop